Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.451.149$

Brown, Michael S. - Aufsichtsrat - Tag der Transaktion: 2023-04-21...…

Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Regeneron (REGN) closed at $800.73, marking a +0.33% move from the previous day....…

Regeneron Pharmaceuticals Chairman P. Roy Vagelos to Retire

Regeneron Pharmaceuticals Chairman P. Roy Vagelos to Retire...…

Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary

Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to…

Regeneron Pharmaceuticals: Kursziel gekürzt

New York (www.aktiencheck.de) - Rating-Update: Das Anlagevotum der Analysten von Morgan Stanley für die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075,…

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., April 11, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…

Regeneron Pharmaceuticals Q1 one-off charges to be ~$56M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K REGENERON PHARMACEUTICAL For: Apr 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?

Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 81.931$

Ryan, Arthur F. - Aufsichtsrat - Tag der Transaktion: 2023-04-03...…

Insiderhandel: EVP Commercial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 900.680$

Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-04-03...…

Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023

TARRYTOWN, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will…

Regeneron (REGN) Gains But Lags Market: What You Should Know

Regeneron (REGN) closed at $821.67 in the latest trading session, marking a +1.25% move from the prior day....…

Regeneron Pharmaceuticals: Kurszielanhebung

New York (www.aktiencheck.de) - Rating-Update: Akash Tewari, Analyst von Jefferies & Co, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075,…

Regeneron in research agreement with Xeris Biopharma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity?

Sanofi and Regenerons top-selling drug could soon be approved to treat yet another disease....…

Regeneron Pharmaceuticals: "buy"

Wien (www.aktiencheck.de) - Rating-Update: Hans Engel, Analyst von Erste Group Research, nimmt die Coverage für die Aktie von Regeneron Pharmaceuticals Inc.…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 829.234$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-03-28...…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 150.372$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-03-27...…

Form 8-K REGENERON PHARMACEUTICAL For: Mar 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Libtayo gets expanded approval in EU for lung cancer subtype

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals: Kursziel angehoben

San Francisco (www.aktiencheck.de) - Rating-Update: Mohit Bansal, Analyst von Wells Fargo Advisors, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…

Regeneron to pay Sonoma $75M upfront in pact to develop autoimmune disease drugs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals: Kursziel erhöht

Milwaukee (www.aktiencheck.de) - Rating-Update: Die Analysten von Robert W. Baird stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…

Regeneron Partners With Sonoma Biotherapeutics To Develop T Cell Therapies

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) and Sonoma Biotherapeutics, Inc. Tuesday announced partnership to discover, develop and sell T…

Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an…

Regeneron Pharmaceuticals: Kurszielerhöhung

London (www.aktiencheck.de) - Rating-Update: Carter Gould, Analyst von Barclays, bestätigt das Rating "overweight" für die Aktie von Regeneron Pharmaceuticals Inc. (ISIN:…

Regeneron Pharmaceuticals: Upgrade

New York (www.aktiencheck.de) - Rating-Update: Akash Tewari, Analyst von Jefferies & Co, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075,…

Insiderhandel: President and Chief Scientific verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.940.376$

Yancopoulos, George - Vorstand - Tag der Transaktion: 2023-03-23...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 1.014.320$

Bassler, Bonnie L. - Aufsichtsrat - Tag der Transaktion: 2023-03-24...…

Insiderhandel: SVP Controller verkauft Aktien von Regeneron Pharmaceuticals im Wert von 1.767.782$

Fenimore, Christopher R. - Vorstand - Tag der Transaktion: 2023-03-23...…

Final Trades: Regeneron, Hess & Bank of America

The "Halftime Report" traders give their top picks to watch for the second half....…

The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly

Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog....…

Regeneron, Sanofi Look for Billions From COPD Drug

The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease....…

Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the Phase 3 trial of Dupixent (dupilumab), developed with Sanofi (NASDAQ: SNY), for uncontrolled chronic…

Regeneron draws more bullish views from analysts after Dupixent COPD data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron (REGN) Soars 6.8%: Is Further Upside Left in the Stock?

Regeneron (REGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…

Health Care Down as Sanofi, Regeneron Rise -- Health Care Roundup

Health Care Down as Sanofi, Regeneron Rise -- Health Care Roundup...…

Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD

Sanofi and Regeneron unveiled data on their jointly developed drug for a difficult-to-treat chronic lung disorder that analysts say "exceeded…

Why Shares of Regeneron Are Rising Thursday

Regeneron released positive phase 3 trial results for its therapy Dupixent....…

Regeneron up 7% following Dupixent data, Raymond James upgrade

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Coinbase’ stock tumbles on SEC warning, while First Republic and Regeneron shares rally, and other stocks on the move

Coinbase, Chewy, Regeneron, Accenture and First Republic were some of the most active shares on Thursday....…

Regeneron, Sanofi say Dupixent works in COPD

Shares of Regeneron Pharmaceuticals Inc. REGN rallied about 7% in premarket trading on Thursday after the company said a pivotal…

Sanofi erzielt Studienerfolg mit Dupixent bei COPD

Von Adria Calatayud PARIS (Dow Jones)--Sanofi hat einen Studienerfolg mit seinem gemeinsam mit Regeneron Pharmaceuticals entwickelten Medikament Dupixent zur…

Sanofi And Regeneron Say Phase 3 Study Of Dupixent To Treat COPD Meets Endpoints

PARIS (dpa-AFX) - Sanofi S.A. (SNYNF) and Regeneron Pharmaceuticals, Inc. (REGN) on Thursday said late-stage study of their Dupixent for…

Regeneron (REGN) Gets Label Extension for Cholesterol Drug

Regeneron (REGN) gets FDA approval for Evkeeza to treat children aged 5 to 11 with homozygous familial hypercholesterolemia....…

Regeneron: FDA Approves Evkeeza To Treat Ultra-rare Form Of High Cholesterol In Young Children

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) said that the U.S. Food and Drug Administration has approved Evkeeza (evinacumab-dgnb) to…

Regeneron: FDA Extends Evkeeza Approval to Children Ages 5 to 11 >REGN

Regeneron: FDA Extends Evkeeza Approval to Children Ages 5 to 11 >REGN...…

Regeneron (REGN) Gains But Lags Market: What You Should Know

Regeneron (REGN) closed the most recent trading day at $759.76, moving +0.07% from the previous trading session....…

Sanofi, Regeneron Dupixent gets approval in EU to treat eczema in kids over 6 months

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…